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Dorsal root ganglia (DRG) sensory neurons arise
from heterogeneous precursors that differentiate in
two neurogenic waves, respectively controlled by
Neurog2 andNeurog1. We show here that transgenic
mice expressing a Zeb1/2 dominant-negative form
(DBZEB) exhibit reduced numbers of nociceptors
and altered pain sensitivity. This reflects an early
impairment of Neurog1-dependent neurogenesis
due to the depletion of specific sensory precursor
pools, which is slightly later partially compensated
by the contribution of boundary cap cells (BCCs).
Indeed, combined DBZEB expression and genetic
BCCs ablation entirely deplete second wave precur-
sors and, in turn, nociceptors, thus recapitulating the
Neurog1/ neuronal phenotype. Altogether, our re-
sults uncover roles for Zeb family members in the
developing DRGs; they show that the Neurog1-
dependent sensory neurogenesis can be functionally
partitioned in two successive phases; and finally,
they illustrate plasticity in the developing peripheral
somatosensory system supported by the BCCs,
thereby providing a rationale for sensory precursor
diversity.
INTRODUCTION
The multiple sensory neuron subtypes of the dorsal root ganglia
(DRG) arise from neural crest cells (NCCs) that migrate and
differentiate in tightly temporally and spatially regulated phases.
In mice, NCCs dedicated to the DRGs leave the neural tube be-
tween embryonic day (E)9 and E10 (Serbedzija et al., 1990) and
differentiate in two main, partially overlapping, neurogenic
waves respectively controlled by the proneural activity of the
bHLH transcription factors Neurog2 and Neurog1. Between
E9.5 and E11.5 the first Neurog2-dependent wave generates
Ret-positive(+) and/or TrkB+ and/or TrkC+mechano- and propri-
oceptors as well as large diameter TrkA+ neurons (lTrkA). TheDevsecond Neurog1-dependent wave occurs between E10.5 and
E13.5 and produces few TrkB+ and TrkC+ neurons as well as
small diameter thermonociceptive neurons, which all express
TrkA at early stages (sTrkA) and subsequently diverge into
‘‘TrkA+ peptidergic’’ and ‘‘Ret+ non-peptidergic’’ nociceptors
(Lawson and Biscoe, 1979; Frank and Sanes, 1991; Ma et al.,
1999; Marmige`re and Ernfors, 2007; Bourane et al., 2009; Bachy
et al., 2011; Lallemend and Ernfors, 2012; Figure S3A). Studies in
chick embryos have revealed that second wave precursors form
a heterogeneous population (George et al., 2007, 2010). In line
with this, boundary cap cells (BCCs) which are involved in struc-
turing spinal nerve roots (Vermeren et al., 2003), have been
shown by lineage studies to also directly contribute to about
5% of nociceptors, as well as satellite cells of the mouse
DRGs (Maro et al., 2004). It is proposed that BCCs represent a
reservoir of neural precursors, an issue supported by their
stem cell like properties in vitro (Hjerling-Leffler et al., 2005),
but so far hardly assessed in physiopathological conditions
in vivo. Here, we addressed the collective roles of Zeb1 and
Zeb2 in the early phases of DRG formation. Both proteins form
a small family of transcription factors harboring two zinc-finger
domains and a homeodomain, involved in many key develop-
mental and physiopathological processes, including epithelio-
mesenchymal transitions and the formation of NCCs-derived
tissues (Gheldof et al., 2012). Although present in the developing
DRGs (Darling et al., 2003; Bassez et al., 2004; Van de Putte
et al., 2007; see also Figure S2), their function remains largely un-
known. Because of potential functional redundancy, we gener-
ated a transgenic mousemodel conditionally expressing the first
zinc finger domain of the Human ZEB1 protein (hereafter referred
to as DBZEB; Sabourin et al., 2009), known to counteract Zeb1
and Zeb2 activity in vitro (Postigo and Dean, 1997). We report
that induction of DBZEB in NCCs specifically impairs the onset
of the second Neurog1-dependent sensory neurogenic wave
due to the early death of specific precursor pools. This notably
leads to drastic, albeit not complete, depletion of nociceptors
and altered pain sensitivity in adulthood. We also show that
this initial defect of the Neurog1-dependent neurogenesis is
slightly later partially compensated by the BCCs. Indeed, com-
bined DBZEB expression and genetic BCCs ablation lead to
complete depletion of second wave precursors and, in turn,
of nociceptors, fully recapitulating the Neurog1/ phenotype.elopmental Cell 33, 343–350, May 4, 2015 ª2015 Elsevier Inc. 343
Figure 1. Impaired Response to Noxious
Stimuli of DBZEB;HtpACre Mice Correlates
with Reduced Numbers of Sensory Noci-
ceptors
(A) Rotarod test, mechanical (von Frey), thermal
(Hargreaves), and chemical (formalin) nocicep-
tive tests performed on wild-type (WT) and
DBZEB;HtpACre (DH) adults, showing reduced
pain sensitivity in transgenic mice. It is of note that
both acute and late phase responses to formalin
injectionwere significantly decreased in transgenic
animals. Data are represented as mean ± SEM and
**p < 0.01.
(B and C) Representative images of WT (B) and
DBZEB;HtpACre (DH) (C) adult thoracic DRGs.
(D) Relative quantification of Trk+ and Ret+ neurons
in adult thoracic DRGs from WT and DBZEB;
HtpACre (DH) animals. Data are represented as
mean ± SEM and *** p < 0.001.
(E–H) Immunofluorescent staining for TrkA on
transverse thoracic DRG sections of E13.5 WT (E),
DBZEB;HtpACre (DH) (F), DBZEB;Wnt1Cre (G),
and DBZEB;Islet1Cre (H) embryos.
(I) Relative quantification of Trk+ neurons in
thoracic DRGs from E13.5 WT, DBZEB;HtpACre
(DH),DBZEB;Wnt1Cre (DW), andDBZEB;Islet1Cre
(DI) embryos. TrkA+ neurons are greatly reduced
in DH (63% ± 9%) and DW (55% ± 5%), but
not in DI embryos. TrkB+ (25% ± 8%) and
both TrkB+ (28% ± 1.5%) and TrkC+ (17% ± 4.5%) neurons were also significantly reduced in DH and DW embryos, respectively.
Data are represented as mean ± SEM; ***p < 0.001; **p < 0.01; and *p < 0.05. Scale bars, 50 mm. See also Figure S1.This illustrates in vivo the participation of the BCCs in ensuring
developmental plasticity of the somatosensory system, notably
for nociceptive neuron formation.
RESULTS AND DISCUSSION
Impaired Sensitivity of Adult DBZEB;HtpACre Mice to
Noxious Stimuli Reflects Reduced Numbers of Sensory
Nociceptive Neurons
First, we tested whether induction of DBZEB in the peripheral
nervous system triggered some of the phenotypes reported in
Zeb knockout mice. Notably, Zeb2cKO/cKO;Wnt1Cre embryos
exhibit developmental defects in the enteric and sympathetic
systems (Van de Putte et al., 2007) that we also observed in
DBZEB;Wnt1Cre animals (Figure S1). This shows that DBZEB
is a potent blocker of at least some aspects of Zeb activity
also in vivo, thus establishing the DBZEB transgenic line as a
malleable model to study roles of Zeb1 and Zeb2 and their
associated human diseases: Polymorphous posterior corneal
dystrophy type 3 and Mowat-Wilson syndrome, respectively.
Interestingly, some ZEB1 and ZEB2 mutations reported in
patients possibly produce truncated proteins, which may act
as dominant-negative (Krafchak et al., 2005; Mowat et al., 2003).
Because Zeb2 is involved in vagal NCCs delamination (Van de
Putte et al., 2007), to assess Zeb function in the forming DRGs,
we primarily used the HtpACre line, which drives Cre expression
in post-emigrating NCCs (Pietri et al., 2003). Adult DBZEB;
HtpACremice are viable, allowing behavioral studies. In contrast
to the rotarod test, during which transgenic animals behaved
normally, thus revealing no major motor deficits, in classical
mechanical (von Frey assay), thermal (Hargreaves assay), and344 Developmental Cell 33, 343–350, May 4, 2015 ª2015 Elsevier Incchemical (formalin assay) nociceptive tests, they exhibited sig-
nificant reduced pain sensitivity (Figure 1A). A rough anatomical
evaluation of the DRGs revealed an obvious size reduction in
transgenic mice, particularly at thoracic levels (Figures 1B and
1C). Expression analyses of Ret and Trk receptors showed that
while mechano- and proprioceptive neurons were present in
close to normal numbers at this stage, there was a reduction
of about 60% of both TrkA+ and Ret+ nociceptive populations
in DBZEB;HtpACre mice (Figure 1D). At more caudal levels,
this phenotype was milder although nociceptors were reduced
by 40% (data not shown). These findings are reminiscent of
the impaired sensitivity of Zeb2 heterozygous mice to thermal-
and formalin-induced pain (but not mechanical pain) due to
altered ion channel expression and slight reduction of nociceptor
numbers (Jeub et al., 2011; Pradier et al., 2014). While these data
further reinforce the reliability of DBZEB effects, they also show
that DBZEB expression triggers a stronger phenotype than
removing only one allele of Zeb2, likely explaining why mechan-
ical pain is also affected in our model.
To determine the etiology of these defects, we analyzed em-
bryonic stages, focusing on thoracic levels. At E13.5, when sen-
sory neurogenesis is nearly complete, we already observed a
63% reduction (±9%) of sTrkA+ nociceptors in DBZEB;HtpACre
embryos (Figures 1E, 1F, and 1I). Interestingly, we found similar
results in DBZEB;Wnt1Cre animals (Figures 1G and 1I), demon-
strating that induction ofDBZEB in pre-migrating NCCs does not
cause a general failure of delamination, but rather alters specific
populations. It is of note that at this stage, TrkB+ and both TrkB+
and TrkC+ populations were also slightly reduced in DBZEB;
HtpACre andDBZEB;Wnt1Cre embryos, respectively (Figure 1I),
a discrepancy likely due to differences in timing and/or levels of.
Figure 2. Impaired Onset of the Second Sensory Neurogenic Wave
in DBZEB;HtpACre Embryos Is Linked to Depletion of Neurog1+
Precursors
(A–L) In situ hybridization on transverse thoracic sections of E11.5WT (A, D, G,
and J), DBZEB;HtpACre (DH) (B, E, H, and K), and Neurog1/ (C, F, I, and L)
DevCre expression. The fact that TrkB+ neurons were not signifi-
cantly affected at adult stages in DBZEB;HtpACre mice may
possibly reflect a ‘‘normalizing effect’’ of the period of naturally
occurring sensory neuron death. Finally, we also found that spe-
cificDBZEB induction in post-mitotic neurons using the Islet1Cre
line did not alter the integrity of the DRGs at E13.5 (Figures 1H
and 1I), suggesting early requirements of Zeb1/2 proteins at
the precursor level.
ImpairedOnset of theSecondSensory NeurogenicWave
in DBZEB Transgenic Embryos Is Linked to Depletion of
Specific Neurog1+ Precursor Populations
The early neuronal depletion triggered by DBZEB was reminis-
cent of some features of the Neurog1/ mutant phenotype
(Ma et al., 1999; see also Figures 4S, 4V, and 4W), which promp-
ted us to assess the neurogenic waves of the forming DRGs (Fig-
ure S3A). As predicted by the relatively mild alteration of TrkB+
and TrkC+ populations, analyses of DBZEB;HtpACre embryos
at E9.5 and E10.5 revealed that the first Neurog2-dependent
neurogenesis occurred largely normally in these animals (Figures
S3B–S3G’). In contrast, in E11.5 DBZEB;HtpACre embryos, at
the peak of the second neurogenic wave, we found altered
expression of the neuronal differentiation marker NeuroD (Fig-
ures 2A and 2B), strikingly comparable to Neurog1/ mutants
(Figure 2C), in which residual NeuroD+ cells reflect the last neu-
rons issued from the first Neurog2-dependent wave (Ma et al.,
1999). In line with this, there was an equal reduction of about
70%of the overall TrkA+ population in both genetic backgrounds
at this stage, specifically affecting the sTrkA+ neurons (Figures
2D–2F and 2M). This shows that the onset of the second neuro-
genic wave is specifically impaired in DBZEB transgenic mice.
Furthermore, we concomitantly found a 65% reduction (±12%)
of Sox10+ precursors in DBZEB;HtpACre embryos (Figures 2G,
2H, and 2N), in contrast to Neurog1/ mutants, in which close
to normal numbers of Sox10+ cells were still present at this stage
(Figures 2I and 2N) and rather diminished subsequently (data not
shown). This reveals that at the precursor level DBZEB;HtpACre
embryos exhibit a stronger phenotype than Neurog1/mutants
at E11.5. Moreover, time course analysis of Neurog1 expressionembryos using NeuroD (A–C), TrkA (D–F), Sox10 (G–I), and Neurog1 (J–L)
probes. Arrows in (A)–(C) point toward NeuroD+ cells in the DRGs that are
similarly reduced in DBZEB transgenic embryos and Neurog1/ mutants.
(D)–(F) are high magnifications of DRG sections showing large (arrowheads)
and small (arrows) TrkA+ neurons in WT, while only large TrkA+ neurons in DH
and Neurog1/ embryos.
(M and N) Relative quantification of TrkA+ neurons (M) and Sox10+ cells (N) in
WT, DBZEB;HtpACre (DH), and Neurog1/ embryos at E11.5. Data are rep-
resented as mean ± SEM; ***p < 0.001; and not significant (n.s.).
(O) Relative quantification of Neurog1+ cells between E9.5 and E11.5 at
thoracic levels of WT, DBZEB;HtpACre (DH), and DBZEB;Wnt1Cre (DW) em-
bryos. Data are represented as mean ± SEM; **p < 0.01; and ***p < 0.001.
(P) Quantification of activated Casp3+ (aCasp3+) cells in the DRG anlage of WT
and DBZEB;HtpACre (DH) embryos between E9.5 and E11.5. Data are rep-
resented as mean ± SEM and ***p < 0.001.
(Q–T) Immunofluorescent staining for aCasp3 alone (Q, R, and T) or com-
bined with Neurog1 (S) on transverse DRG sections of E10.5 WT (Q),
DBZEB;HtpACre (DH) (R and S), and Neurog1/ (T) embryos, showing many
apoptotic figures specifically in DH mice, some of which being Neurog1+
(arrowheads in S).
See also Figure S2. Scale bars, 25 mm in (S) and 50 mm elsewhere.
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Figure 3. Partial Recovery of Nociceptors in
DBZEB;HtpACre Embryos from E12 Is
Neurog1 Dependent
(A) Time course analysis of TrkA+ neurons from
E11.5 to E14.5 in WT and DBZEB;HtpACre (DH)
embryos.
(B–G) Data are represented as mean ± SEM. In situ
hybridization on transverse thoracic DRG sections
from WT (B, D, and F) and DH (C, E, and G) em-
bryos at E12.5, using TrkA (B and C), Neurog1
(D and E), andNeuroD (F and G) probes. (B) and (C)
are high magnifications showing the presence of
sTrkA+ neurons in transgenic animals at this stage
(arrows in C).
(H–K) Immunofluorescent staining for TrkA on
transverse thoracic DRG sections from E14.5
WT (H), DBZEB;HtpACre (I), DBZEB;HtpACre;
Neurog1/ (J), and Neurog1/ (K) embryos.
(L) Relative quantification of TrkA+ neurons in
WT, DBZEB;HtpACre (DH), DBZEB;HtpACre;
Neurog1/ (DH1/), andNeurog1/ (1/). Data
are represented as mean ± SEM; *p < 0.001; and
not significant (n.s.). Scale bars, 50 mm.revealed that the primary phase of Neurog1 expression in
first wave precursors initiated at E9.5 under the control of
Neurog2 (Figure S3A; Ma et al., 1999) was normal in transgenic
embryos (Figures 2O, S3D, and S3D’). At E10.5, although
manyNeurog1+ andNeuroD+ cells were still observed, reflecting
the ongoing first neurogenic wave (Figures S3F and S3G’), we
already found a 28% (±3%) reduction of the Neurog1+ popula-
tion (Figure 2O), which reached 62% (±7%) at E11.5 (Figures
2J, 2K, and 2O), thus paralleling the diminution of Sox10+ cells
(Figures 2G, 2H, and 2N). These data, together with the
described roles of Zeb proteins in neural cell survival (Ohayon
et al., 2009; Sabourin et al., 2009; Miquelajauregui et al., 2007),
prompted us to assess cell death. Time course analysis of the
apoptosis marker ‘‘activated Caspase-3’’ (aCasp3) between
E9.5 and E11.5 revealed a massive increase of dying cells spe-
cifically in the DRG anlage of DBZEB;HtpACre embryos at
E10.5 (Figures 2P–2R), some of which being Neurog1+ (Fig-
ure 2S). It is of note that DBZEB;Wnt1Cre embryos exhibited
similar phenotypes (Figures 2O, S3B’’–S3G’’, and S3H–S3K),
although at E10.5 numbers ofNeurog1+ precursors were already
reduced by 43% (±4%; Figure 2O), likely due to temporal and
spatial divergences in apoptosis induction. Indeed, in these
animals, we observed dying cells at E9.5 and E10.5, which
were mainly located in the roof of the neural tube (Figures
S3M–S3O’). Thus, these results indicate that alteration of
Neurog1 expression in DBZEB;HtpACre and DBZEB;Wnt1Cre
mice at E11.5 is the consequence, and not the cause, of
increased apoptosis of second wave precursors, also supported
by the absence of dying cells in Neurog1/ mutants at E10.5
(Figure 2T).346 Developmental Cell 33, 343–350, May 4, 2015 ª2015 Elsevier Inc.Altogether, these data show that induc-
tion of DBZEB in pre- or post-emigrating
NCCs leaves largely intact first wave
precursors undergoing the Neurog2-
dependent neurogenesis and instead
specifically affects the integrity of secondwave precursor pools, leading to impaired onset of theNeurog1-
dependent neurogenic wave. These early effects are consistent
with Zeb expression profiles in the developing DRGs. Neverthe-
less, while all Pax3+ NCCs, including Neurog2+ and Neurog1+
sensory precursors, express Zeb2 from E9.5, they display no
or low levels of Zeb1, which is rather upregulated in Islet1+
post-mitotic neurons (Figure S2). It is thus likely that the pheno-
types triggered by DBZEB mainly reflect alteration of Zeb2
function.
Partial Recovery of Nociceptors in DBZEB Transgenic
Mice Is Neurog1 Dependent
Intriguingly, virtual absence of sTrkA+ neurons at thoracic levels
of E11.5 DBZEB;HtpACre and DBZEB;Wnt1Cre animals con-
trasted with their presence at E13.5 (see Figures 1E–1G and
1I). Time course analysis of TrkA expression indeed showed
that sTrkA+ nociceptors first arise at E12 in transgenic embryos
and expand afterward, though at a lower rate compared to con-
trols (Figures 3A–3C; data not shown). Consistent with this, we
detected Neurog1+ precursors and NeuroD+ differentiating
neurons at E12.5 (Figures 3D–3G), revealing that in contrast to
Neurog1/ mutants (Figure 4P; Ma et al., 1999), the second
neurogenic wave is not totally blocked in transgenic mice, but
is postponed. Furthermore, by analyzing DBZEB;HtpACre;
Neurog1/ embryos at E14.5, we found that, unlike DBZEB;
HtpACre mice, compound mutants exhibited a complete lack
of sTrkA+ neurons, like Neurog1/ mutants (Figures 3H–3L).
These data thus show that the initial impairment of nociceptor
production in DBZEB;HtpACre embryos is slightly later partially
compensated through a Neurog1-dependent mechanism.
CombinedDBZEB Expression andGenetic BCCAblation
Lead to Entire Depletion of Second Wave Precursors
and Recapitulate the Neurog1–/– Neuronal Phenotype
Obviously, a pool of sensory precursors undergoing the
Neurog1-dependent neurogenesis appeared insensitive to
DBZEB. BCCs emerged as good candidates to participate in
this apparent compensatory process since the first sign of their
differentiation is the induction of Egr2 at E10.75, after the second
neurogenic wave has normally started, and the first BCC-derived
neurons arise at E12 (Maro et al., 2004). We first assessed the
status of BCCs in DBZEB transgenic mice using the Egr2LacZ
allele. On whole mount preparations of DBZEB;HtpACre;
Egr2LacZ/+ embryos at E12, we observed reduced numbers of
BCCs all along the anteroposterior axis (Figures 4A and 4C). Ac-
cording to Zeb2 (but not Zeb1) expression in BCCs (Figures S2S
and S2T), this might reflect a direct implication in their develop-
ment. Nevertheless, on dissected DRGs, in contrast to controls
in which X-Gal+ cells were confined around spinal nerve roots
(arrows in Figures 4B and 4D), in transgenic mice, we intriguingly
observed X-Gal staining inside the DRGs (arrowhead in Fig-
ure 4D). In line with this, on sections we occasionally detected
ectopic Egr2+ cells in the DRGs of DBZEB;HtpACre embryos
at E12 (Figures 4E–4H; see also S3L), some of which being
TrkA+ (arrowheads in Figure 4H). Therefore, another possible
non-mutually exclusive explanation to the reduced numbers of
BCCs is that, as a consequence of sensory precursor loss, these
cells abnormally colonize the DRG anlage of DBZEB transgenic
mice. These observations further prompted us to directly assess
whether Egr2+ BCCs indeed support the recovery of nociceptors
in these animals. To test this, we took advantage of the Egr2DT
allele (Vermeren et al., 2003) and mainly used Wnt1Cre,
which, in our hands, was more efficient in triggering BCCs
ablation than HtpACre (data not shown). First, studies of
Wnt1Cre;Egr2DT/+ embryos confirmed that at E13.5 there was
a 55% (±5%) reduction of nociceptors (Figures S4A–S4C;
Maro et al., 2004), as well as a slight reduction of both TrkB+
and TrkC+ populations (18% ± 2% and12% ± 1.5%, respec-
tively; Figure S4C). In addition, analyses at E11.5 revealed that
while the second neurogenic wave was initiated at the right
time in these animals, as illustrated by the presence of many
NeuroD+ and sTrkA+ cells (Figures S4D–S4G), there was a
concomitant 50% reduction of Sox10+ andNeurog1+ precursors
(Figures S4H–S4K; quantified in 4K). These results show that
BCCs ablation leads to the depletion of a Neurog1+ precursor
pool as early as E11.5 that appeared strikingly complementary
to that observed in DBZEB transgenic mice. We next analyzed
DBZEB;Wnt1Cre;Egr2DT/+ compound transgenic embryos and
found that, as early as E11.5, there was a virtual complete loss
of Neurog1+ precursors at thoracic levels (Figures 4I–4K), paral-
leled by a drastic reduction of Sox10+ cells, the remaining ones
typically lying around the DRG anlage and likely constituting
glial precursors (Figures 4L and 4M). Consistent with this, from
E12, complete absence of NeuroD+ differentiating neurons in
compound transgenic mice demonstrated that the second
sensory neurogenic wave was totally impaired, fully mimicking
the Neurog1/ phenotype (Figures 4N–4P). In line with
this, comparative analyses of DBZEB;Wnt1Cre;Egr2DT/+ and
Neurog1/ embryos at E13.5 revealed similar neuronal pheno-
types at thoracic levels, including a virtual absence of sTrkA+Devnociceptors and reduction of about 25% of both TrkB+ and
TrkC+ populations (Figures 4Q–4W; Ma et al., 1999). These re-
sults thus demonstrate complementary deleterious effects of
DBZEB expression and BCCs ablation on DRG formation, lead-
ing to an entire depletion of second wave Neurog1+ precursors,
and in turn, notably to complete agenesis of nociceptive neu-
rons. They also demonstrate that BCCs indeed participate in
the recovery of nociceptors observed inDBZEB transgenicmice.
Taken together, our data illustrate the complex and dynamic
events ensuring the formation of the peripheral somatosensory
system. Using a dominant-negative approach, we uncover roles
of Zeb family members in this system, most likely attributable to
Zeb2 according to expression profile analyses. Although Zeb2 is
a general marker of first and second wave precursors, including
BCCs, DBZEB induction in pre- or post-emigrating NCCs leaves
largely intact the first Neurog2-dependent neurogenic wave and
instead affects the onset of the second Neurog1-dependent
neurogenesis, as the consequence of the early depletion of
specific sensory precursor populations. This notably leads to
drastic, albeit not complete, reduction of nociceptors, thus giv-
ing an explanation for the altered pain sensitivity observed in
adult transgenic animals. The reason for this partial requirement
remains unclear, but supports the view that peripheral somato-
sensory precursors are heterogeneous (Frank and Sanes,
1991; Ma et al., 1999; George et al., 2007, 2010; Maro et al.,
2004). In line with this, combined effects of DBZEB expression
and genetic BCCs ablation, which recapitulate the Neurog1/
phenotype, establish that theNeurog1-dependent neurogenesis
can be functionally partitioned in at least two consecutive
phases involving distinct precursor populations with specific
developmental modalities: a first pool is Zeb-dependent and dif-
ferentiates from E10.5; a second pool is BCCs-dependent and
differentiates slightly later. We also refine the requirement of
BCCs in the forming DRGs by revealing that reduced numbers
of nociceptors previously reported in embryos devoid of BCCs
(Maro et al., 2004) reflect, at least in part, an early depletion of
precursor cells. We also present genetic evidences that in a
context of early nociceptive precursor loss triggered here by
DBZEB, BCCs have the capacity to support the formation of sig-
nificant numbers of nociceptors, which correlates with the pres-
ence of ectopic Egr2+ cells in the DRGs of DBZEB transgenic
mice. Finally, altogether, our data illustrate that Zeb family mem-
bers and BCCs underlie developmental plasticity of nociceptive




Procedures involving animals and their care were conducted according to the
French Ministry of Agriculture and the European Community Council Directive
no. 86/609/EEC, OJL 358. Protocols were validated by the Direction De´parte-
mentale des Services Ve´te´rinaires de l’He´rault (Certificate of Animal Experi-
mentation no. 34-376). DBZEB (Sabourin et al., 2009), HtpACre (Pietri et al.,
2003), Wnt1Cre (Danielian et al., 1998), Islet1Cre (Srinivas et al., 2001),
Neurog1 (Ma et al., 1999), Egr2LacZ (Maro et al., 2004), and Egr2GFPDT (Verme-
ren et al., 2003) mouse strains were used in this study.
Behavioral Tests
Experiments were performed blindly on groups of at least six males and
females from wild-type and DBZEB;HtpACre genotypes.elopmental Cell 33, 343–350, May 4, 2015 ª2015 Elsevier Inc. 347
Figure 4. Combined DBZEB Expression and BCC Ablation Lead to Entire Depletion of Second Wave Precursors and Recapitulate the
Neurog1–/– Neuronal Phenotype
(A–D) X-Gal staining on E12 Egr2LacZ/+ (A and B) and DBZEB;HtpACre;Egr2LacZ/+ (C and D) embryos. (A) and (C) are dorsal views of whole embryos. (B) and (D)
show representative images of dissected DRGs. Arrows point toward the BCCs, while arrowhead points toward ectopic X-Gal+ cells inside the DRGs of
DBZEB;HtpACre;Egr2LacZ/+ mice.
(E–H) In situ hybridization using an Egr2 probe alone (E and G) or combined with a TrkA probe (F and H) on transverse thoracic DRG sections of E12 WT (E and F)
and DBZEB;HtpACre (DH) (G and H) embryos. Arrows point toward Egr2+ BCCs, while arrowheads point toward ectopic Egr2+ cells in the DRGs of DH animals,
some of which being TrkA+ (H).
(I and J) In situ hybridization on transverse thoracic DRG sections from E11.5 WT (I) and DBZEB;Wnt1Cre;Egr2DT/+ (J) embryos using a Neurog1 probe.
(K) Compilation of the relative numbers of Neurog1+ cells in thoracic DRGs of E11.5 WT, DBZEB;Wnt1Cre (DW), Wnt1Cre;Egr2DT/+ (WE), and DBZEB;
Wnt1Cre;Egr2DT/+ (DWE) embryos. Data are represented as mean ± SEM and ***p < 0.001.
(L–P) In situ hybridization on transverse thoracic DRG sections from WT (L and N), DBZEB;Wnt1Cre;Egr2DT/+ (M and O), and Neurog1/ (P) embryos at E11.5
(L and M) or E12.5 (N–P) using Sox10 (L and M) and NeuroD (N–P) probes.
(legend continued on next page)
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Motor Activity
Mice were trained on the Rotarod apparatus at a fixed speed of 10 rotations
per minute (rpm) for 2 consecutive days. They were then tested for the accel-
eration task, during which the speed progressively increased from 4 to 40 rpm
over a 5 min period. The latency to fall was recorded. Data were analyzed by
unpaired t test.
Tactile Sensitivity
Paw-withdrawal thresholds of the hindpaw were determined in response to
probing with calibrated von Frey filaments ranging from 0.4 to 4.0 grams (g).
Mice were allowed to acclimate in suspended wire-mesh cages for 1 hr.
Each filament was applied perpendicularly to the plantar surface of the paw.
Withdrawal thresholds were determined by sequentially increasing and
decreasing the stimulus strength (‘‘up and down’’ method). Data were
analyzed using a Dixon non-parametric test and expressed as the mean with-
drawal threshold. Unpaired t test was used for statistical analysis.
Heat Sensitivity
The method of Hargreaves (Hargreaves et al., 1988) was used to assess paw-
withdrawal latency to a thermal nociceptive stimulus. Mice were allowed to
acclimate in a Plexiglas enclosure on a clear glass plate in a quiet testing
room for 1 hr. A radiant heat source (a high-intensity projector lamp) was
focused onto the plantar surface of the paw. Paw-withdrawal latency was
determined. Each paw was tested three times with a 10 min interval between
each trial. A maximal cutoff time of 20 s was used to prevent tissue damage.
Data were analyzed using unpaired t test.
Nocifensive Behavior
Experimental animals underwent treatment with formalin. Briefly, animals were
subjected to intraplantar injections of sterile 2.5% formalin (10 ml) just under the
skin on the dorsal surface of the hindpaw. Pain responses (licking and biting)
were recorded for a period of 45 min by 5 min intervals. Data were analyzed
by repeated-measures ANOVA followed by Dunnett’s test.
In Situ Hybridization, Immunofluorescence, and X-Gal Staining
Single or double in situ hybridization experiments and immunofluorescent
staining were performed as previously described (Bourane et al., 2009).
Antisense RNA probes for DBH, Egr2, NeuroD, Neurog1, Neurog2, Ret,
Sox10, TrkA, TrkB, and TrkC were labeled using the DIG or Fluorescein RNA
labeling kits (Roche). Primary antibodies used in this study were as follows:
chicken anti-GFP (Abcam); goat anti-Neurog1 (Santa Cruz), Neurog2 (Santa
Cruz), TrkB (R&D Systems), and TrkC (R&D Systems); mouse anti-Islet1/2
(Developmental Studies Hybridoma Bank [DSHB]) and Pax3 (DSHB); and
rabbit anti-aCasp3 (Cell Signaling), TrkA (Millipore), Zeb1 (Darling et al.,
2003), and Zeb2 (Santa Cruz). X-Gal staining was performed as described
(Knittel et al., 1995).
Cell Counts
Quantitative analyses were carried out on at least four independent animals
from each genotype. DRGs sections were imaged using a Zeiss microscope,
and cell counts were performed using the Image J software. Data were statis-
tically analyzed using Student’s t test and represented as mean ± SEM.
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